CD8+/CD161++ mucosal-associated invariant T-cell levels in the colon are restored on long-term antiretroviral therapy and correlate with CD8+ T-cell immune activation

AIDS

Volumn 28, Issue 11, 2014, Pages 1690-1692

  Greathead, Louise ^a   Metcalf, Rebecca ^a   Gazzard, Brian ^b   Gotch, Frances ^a   Steel, Alan ^a   Kelleher, Peter ^a,b  

^a CHELSEA AND WESTMINSTER HOSPITAL   (United Kingdom)

^b Centre for Sexual Health and HIV Research   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; ANTIRETROVIRUS AGENT; KLRB1 PROTEIN, HUMAN; NATURAL KILLER CELL LECTIN LIKE RECEPTOR SUBFAMILY B;

ADULT; ANTIVIRAL THERAPY; ARTICLE; CD8+ T LYMPHOCYTE; CLINICAL ARTICLE; COLON BIOPSY; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; MALE; MUCOSAL ASSOCIATED INVARIANT T CELL; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; CHEMISTRY; COLON; HIV INFECTIONS; IMMUNOLOGY; INTESTINE MUCOSA; MIDDLE AGED; T LYMPHOCYTE SUBPOPULATION;

ADULT; ANTI-RETROVIRAL AGENTS; CD8-POSITIVE T-LYMPHOCYTES; COLON; FEMALE; HIV INFECTIONS; HUMANS; INTESTINAL MUCOSA; MALE; MIDDLE AGED; NK CELL LECTIN-LIKE RECEPTOR SUBFAMILY B; T-LYMPHOCYTE SUBSETS;

EID: 84904725893     PISSN: 02699370     EISSN: 14735571     Source Type: Journal    
DOI: 10.1097/QAD.0000000000000351     Document Type: Article

References (9)

1. Billerbeck E, Kang YH, Walker L, Lockstone H, Grafmueller S, Fleming V, et al. Analysis of CD161 expression on human CD8+ T cells defines a distinct functional subset with tissuehoming properties. Proc Natl Acad Sci U S A 2010; 107: 3006-3011.
2. Kjer-Nielsen L, Patel O, Corbett AJ, Le Nours J, Meehan B, Liu L, et al. MR1 presents microbial vitamin B metabolites to MAIT cells. Nature 2012; 491: 717-723.
3. Leeansyah E, Ganesh A, Quigley MF, Sönnerborg A, Andersson J, Hunt PW, et al. Activation, exhaustion, and persistent decline of the antimicrobial MR1-restricted MAIT-cell population in chronic HIV-1 infection. Blood 2013; 121: 1124-1135.
4. Cosgrove C, Ussher JE, Rauch A, Gärtner K, Kurioka A, Hühn MH, et al. Early and nonreversible decrease of CD161RR/MAIT cells in HIV infection. Blood 2013; 121: 951-961.
5. Brenchley JM, Price DA, Schacker TW, Asher TE, Silvestri G, Rao S, et al. Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nat Med 2006; 12: 1365-1371.
6. Kaltsidis H, Cheeseman H, Kopycinski J, Ashraf A, Cox MC, Clark L, et al. Measuring human T cell responses in blood and gut samples using qualified methods suitable for evaluation of HIV vaccine candidates in clinical trials. J Immunol Methods 2011; 370: 43-54.
7. Sandberg JK, Dias J, Shacklett BL, Leeansyah E. Will loss of your MAITs weaken your HAART? AIDS 2013; 27: 2501-2504.
8. Kim CJ, Nazli A, Rojas OL, Chege D, Alidina Z, Huibner S, et al. A role for mucosal IL-22 production and Th22 cells in HIV-Associated mucosal immunopathogenesis. Mucosal Immunol 2012; 5: 670-680.
9. Giorgi JV, Hultin LE, McKeating JA, Johnson TD, Owens B, Jacobson LP, et al. Shorter survival in advanced human immunodeficiency virus type 1 infection is more closely associated with T lymphocyte activation than with plasma virus burden or virus chemokine coreceptor usage. J Infect Dis 1999; 179: 859-870.